Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 13(1): 22434, 2023 12 17.
Artigo em Inglês | MEDLINE | ID: mdl-38104179

RESUMO

The aim of this study was to investigate factors affecting total, true protein and lactoferrin (Lf) concentrations in human milk (HM) and to evaluate the changes in protein concentrations over the course of lactation (first to sixth month postpartum). HM samples were collected from exclusively breastfeeding mothers during six time periods (1-6 months postpartum); 198 breast milk samples were collected in total. The concentrations of total and true protein in HM were determined using the MIRIS human milk analyzer (HMA). The assessment of HM protein content was also performed in skim HM samples and quantified by bicinchoninic methods with the Bicinchoninic Acid Protein Assay Kit. In turn, Lf content in skim HM samples was determined by the enzyme-linked immunosorbent assay (ELISA) in accordance with a slightly modified procedure. In the first month of lactation total protein concentration was negatively correlated with maternal pre-pregnancy BMI (r = - 0.397; p = 0.022), whereas in the third month postpartum, positive correlation with maternal age was found (r = 0.399; p = 0.021). Considering Lf concentration, in the first month of lactation, it was positively correlated with baby's birth weight (r = 0.514; p = 0.002). In the next months (from second to sixth) no relationships between Lf concentration and maternal and infants' factors were observed. The concentration of protein and Lf in HM changes dynamically throughout lactation. Maternal and infant characteristics may impact the HM protein and Lf content, especially in the first month postpartum.


Assuntos
Lactoferrina , Leite Humano , Lactente , Gravidez , Feminino , Humanos , Leite Humano/química , Lactoferrina/metabolismo , Lactação/metabolismo , Aleitamento Materno , Período Pós-Parto , Proteínas do Leite/metabolismo
2.
Nutrients ; 13(12)2021 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-34959890

RESUMO

BACKGROUND: The Iowa Infant Feeding Attitude Scale (IIFAS), which is used for the assessment of attitudes towards breastfeeding, has been found to be reliable and valid in a number of countries, but has not yet been psychometrically tested in Polish women. The purpose of the study was to report on the cultural adaptation of the IIFAS to Polish settings and on its validation, to evaluate the breastfeeding attitudes in Polish women who recently gave birth, and to identify the determinants of these attitudes. METHODS: The study was performed in a group of 401 women in their first postpartum days. RESULTS: Cronbach's α for the scale was 0.725. Discriminative power coefficients of all questionnaire items were higher than 0.2. Subscales were strongly correlated with the total score, with a correlation coefficient of 0.803 for the "favorable toward breastfeeding" subscale (p < 0.001), and 0.803 for the "favorable toward formula feeding" subscale (p < 0.05). For the item "A mother who occasionally drinks alcohol should not breastfeed her baby", the factor loading did not reach the criterion value, and so the item was not included in further analyses. The mean IIFAS score was 63.12 (±7.34). CONCLUSIONS: The Polish version of the IIFAS is a reliable and appropriate measure of women's attitudes towards infant feeding in Polish settings, with acceptable psychometric properties and construct validity.


Assuntos
Aleitamento Materno/psicologia , Conhecimentos, Atitudes e Prática em Saúde , Mães/psicologia , Período Pós-Parto/psicologia , Escalas de Graduação Psiquiátrica/normas , Adulto , Assistência à Saúde Culturalmente Competente/normas , Feminino , Humanos , Polônia , Psicometria , Reprodutibilidade dos Testes , Traduções
3.
Ann Agric Environ Med ; 24(3): 513-516, 2017 Sep 21.
Artigo em Inglês | MEDLINE | ID: mdl-28954500

RESUMO

INTRODUCTION: Endometrial cancer (EC) is the most common gynaecological malignancy in developed countries. Effective treatment of the early stage of the disease is achieved by surgery alone. An increasing number of patients with EC become long-term survivors; therefore, the purpose of this study was to investigate the quality-of-life (QOL) of EC survivors. MATERIALS AND METHOD: A total of 328 survivors who had completed cancer treatment more than 3 years ago, and had previously completed questionnaires concerning QOL - European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and depression - Beck Depression Inventory-II (BDI-II). Patients were grouped into those with surgery alone or surgery with adjuvant radiotherapy. Responses were compared with 284 healthy women who were seen for standard gynaecologic screening examinations. RESULTS: According to the presented results, the QOL of women with EC after surgical treatment was equal to that of healthy women in the control group. Treatment with adjuvant radiotherapy influenced the QOL, with the exception of emotional functioning (p=0.028). No statistically significant differences were found in scores on the BDI-II between groups for the cognitive-affective factor, the somatic factor, or the total sum score. CONCLUSIONS: The quality of life in EC survivors approximates that of healthy controls after 3 years post-surgical treatment. Patients treated for early stage EC should be informed about the anticipated good prognosis and the low risk of psychosocial and physical long-term effects. Cancer survivors who are treated by surgery and adjuvant radiotherapy may be especially at risk for emotional functioning problems.


Assuntos
Sobreviventes de Câncer/psicologia , Neoplasias do Endométrio/psicologia , Idoso , Neoplasias do Endométrio/terapia , Feminino , Humanos , Pessoa de Meia-Idade , Qualidade de Vida , Inquéritos e Questionários , Sobreviventes
4.
Tumour Biol ; 36(6): 4157-65, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25577253

RESUMO

The second mitochondria-derived activator of caspase (Smac/DIABLO), vascular endothelial growth factor (VEGF), and survivin are known to play a significant role in the growth and development of numerous tumors. Serum concentrations of VEGF, survivin, and Smac/DIABLO were analyzed in 92 patients with serous ovarian cancer and 94 healthy controls. Values were correlated with clinicopathological characteristics and outcomes. The median pretreatment serum VEGF and survivin levels in patients with serous ovarian carcinoma were significantly higher, while Smac/DIABLO levels were significantly lower than that in healthy controls. Receiver operating characteristic (ROC) curve analysis showed that the best cutoff point for VEGF was determined to be 345 pg/ml; with 83 % sensitivity and 65 % specificity. For survivin, the cutoff point was 110 pg/ml and for Smac/DIABLO was 75 pg/ml, with 82 and 62 % sensitivity and 43 and 87 % specificity, respectively. In the patients group, higher VEGF and survivin levels and lower Smac/DIABLO levels in sera were significantly associated with poorer overall survival (OS) and disease-free survival (DFS). Preoperative measurement of serum VEGF, survivin, and Smac/DIABLO may be of help in early detection of serous ovarian cancer and may provide important information about the patient's outcome and prognosis.


Assuntos
Cistadenocarcinoma Seroso/sangue , Proteínas Inibidoras de Apoptose/sangue , Peptídeos e Proteínas de Sinalização Intracelular/sangue , Proteínas Mitocondriais/sangue , Neoplasias Ovarianas/sangue , Fator A de Crescimento do Endotélio Vascular/sangue , Adulto , Apoptose/genética , Proteínas Reguladoras de Apoptose , Biomarcadores Tumorais/sangue , Cistadenocarcinoma Seroso/genética , Cistadenocarcinoma Seroso/patologia , Intervalo Livre de Doença , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mitocôndrias/genética , Mitocôndrias/patologia , Neoplasias Ovarianas/genética , Neoplasias Ovarianas/patologia , Período Pré-Operatório , Prognóstico , Survivina
5.
Eur Cytokine Netw ; 24(3): 106-13, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24197277

RESUMO

In the present study, associations between pretreatment interleukin 6 (IL-6), interleukin 8 (IL-8) and C-reactive protein (CRP) serum levels and epithelial ovarian cancer (EOC) were analyzed using commercially available, enzyme-linked immunosorbent assay (ELISA) in 118 patients and 64 control subjects. Values were correlated with clinicopathological characteristics and outcomes. Control variables included age, stage, grade, histological type and residual tumor size. Kaplan-Meier plots and univariate and multivariate Cox proportional hazards models were used to study the associations between IL-6, IL-8 and CRP levels, control variables, overall survival and disease-free survival. The median IL-6, IL-8 and CRP serum levels in EOC were significantly higher than in the normal control group; 11.5 pg/mL (range, 3.4-62.6) versus 2.9 (1.1-12.3) pg/mL (p<0.001) and 21.8 pg/mL (range, 16.4-105.3) versus 9.3 (4.3-32.4) pg/mL (p<0.001) and 9.51 mg/L (range, 0.3-129.2) versus 1.2 (0.1-11.5) mg/L (p = 0.001), respectively. High levels of IL-6, IL-8 and CRP were associated with reduced overall survival (P = 0.003, P = 0.035, P = 0.046) and disease-free survival (P<0.001, P = 0.026, P = 0.043), respectively. Multivariate analyses showed that IL-6, IL-8 and CRP serum levels independently predicted disease-free survival (P = 0.011, P = 0.001 and P = 0.021), and overall survival (P = 0.004, P = 0.014 and P = 0.016), respectively. EOC is associated with extensive changes in the serum cytokine environment, highlighting the importance of further investigations of relative cytokine level changes. Preoperative serum IL-6, IL-8, and CRP levels seem promising for distinguishing EOC patients from healthy controls; however, their clinical value is still to be confirmed. High levels of IL-6, IL-8, and CRP in EOC patients have been suggested to be a poor prognostic factor for OS and DFS.


Assuntos
Proteína C-Reativa/metabolismo , Interleucina-6/sangue , Interleucina-8/sangue , Neoplasias Epiteliais e Glandulares/sangue , Neoplasias Epiteliais e Glandulares/patologia , Neoplasias Ovarianas/sangue , Neoplasias Ovarianas/patologia , Adulto , Idoso , Carcinoma Epitelial do Ovário , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Pessoa de Meia-Idade , Prognóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...